TrialThe lancet. HIV2021

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Onyema Ogbuagu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.